New York, New York Clinical Trials

A listing of New York, New York clinical trials actively recruiting patient volunteers.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials
Languages supported at study center
Age Group

Male only (58)
Female only (46)
Transgender (2)
Non-Binary (2)
Any (330)

Phase 0 (24)
Phase 1 (39)
Phase 1/2 (6)
Phase 2 (23)
Phase 2/3 (3)
Phase 3 (20)
Phase 3/4 (1)
Phase 4 (12)
Unknown (295)

Interventional (109)
Observational (31)

Memorial Sloan Kettering Cancer Center (16)
Genzyme, a Sanofi Company (12)
Sanofi (10)
NYU Langone Health (8)
Columbia University (7)
Weill Medical College of Cornell University (5)
TrialX (4)
Eli Lilly and Company (3)
Icahn School of Medicine at Mount Sinai (3)
AstraZeneca (2)
Celgene (2)
Genentech, Inc. (2)
Hoffmann-La Roche (2)
Montefiore Medical Center (2)
National Cancer Institute (NCI) (2)
Pfizer (2)
University of Arkansas, Fayetteville (2)
pfizer (2)
AbbVie (1)
Acrotech Biopharma Inc. (1)
Actelion (1)
Albert Einstein College of Medicine (1)
Alector Inc. (1)
Arcus Biosciences, Inc. (1)
Autolus Limited (1)
BTL Industries Ltd. (1)
Bayer (1)
BelleTorus Corporation (1)
BioTheryX, Inc. (1)
Bolt Biotherapeutics, Inc. (1)
Boston Image Reading Center (1)
Center for Human Reproduction (1)
Chalmers University of Technology (1)
Corvus Pharmaceuticals, Inc. (1)
DARTNet Institute (1)
Derek Richards (1)
Duke University (1)
Edwards Lifesciences (1)
Entrada Therapeutics, Inc. (1)
Epax Norway AS (1)
Epizyme, Inc. (1)
Gregory Wallace (1)
Imperial College London (1)
InSightec (1)
Intervene, Inc. (1)
JenaValve Technology, Inc. (1)
Juno Therapeutics, a Subsidiary of Celgene (1)
K36 Therapeutics, Inc. (1)
Karyopharm Therapeutics Inc (1)
McGill University (1)
Medtronic (1)
Medtronic Cardiac Rhythm and Heart Failure (1)
Medtronic Endovascular (1)
Michael J. Fox Foundation for Parkinson's Research (1)
MimiVax, LLC (1)
Natalia organization (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
NextCure, Inc. (1)
Northwell Health (1)
Novartis Pharmaceuticals (1)
Orthopaedic Department of General University Hospital of Laria (1)
Pluristem Ltd. (1)
Poseida Therapeutics, Inc. (1)
ProofPilot (1)
Pulmoquine Therapeutics, Inc (1)
Q-Med AB (1)
REEV LLC (1)
Sanofi Pasteur, a Sanofi Company (1)
Shengjing Hospital (1)
Shiraz University of Medical Sciences (1)
Stergios Zacharoulis (1)
Tehran University of Medical Sciences (1)
The New York Stem Cell Foundation (1)
Universitat Jaume I (1)
University Hospital, Montpellier (1)
University of Alabama at Birmingham (1)
University of California, Los Angeles (1)
University of Cincinnati (1)
University of Medicine and Pharmacy at Ho Chi Minh City (1)
University of Michigan (1)
University of Pennsylvania (1)
University of Southern California (1)
VAXX (1)
Yale University (1)
me (1)
test12 (1)
x sponse (1)

No (388)
Yes (50)

Updated trials (1)

No (414)
Yes (24)

English (28)
Hindi (11)
Arabic (8)
Argentinian Spanish (7)
Azerbaijani (7)
Spanish (7)
Albanian (6)
Australian English (6)
British English (5)
Armenian (4)
Asturian (4)
Basque (3)
Brazilian Portuguese (2)
Chinese (2)
Colombian Spanish (2)
French (2)
Norwegian Bokmål (2)
Breton (1)
Burmese (1)
Frisian (1)
Hebrew (1)
Japanese (1)
Mexican Spanish (1)
Persian (1)
Polish (1)
Portuguese (1)
Russian (1)

Adult (18+) (420)
Pediatric (Under 18) (328)

I am/have/had

I am/have/hadcough

I am/have/hadmetastatic hormone refractory prostate cancer

I am/have/hadstereotactic body radiation therapy

I am/have/hadcarcinoma

I am/have/hadcancer therapy

I am/have/hadoophorectomy

I am/have/hadoestrogen receptor positive breast cancer

I am/have/hadfollicular lymphoma

I am/have/hadrecurrent disease

I am/have/hadcancer

I am/have/hadhodgkin's disease

I am/have/hadmetastatic castration-resistant prostate cancer

I am/have/hadmeasurable disease

I am/have/hadprostate cancer

I am/have/hadhepatitis

I am/have/hadcns metastases

I am/have/hadmyelodysplastic syndrome

I am/have/hadbone marrow procedure

I am/have/haddyspnea

I am/have/hadoximetry

added new label for I am/have/had

I am looking for

I am looking forlenalidomide

I am looking foralkylating agents

I am looking forchloroquine

I am looking fororal contraceptives

I am looking forendocrine therapy

I am looking forestradiol

I am looking forgonadotropin releasing hormone

I am looking foretoposide

I am looking fordrug trials

I am looking foratezolizumab

I am looking forandrogens

I am looking forgrowth factor

I am looking forcorticosteroids

I am looking forproteasome inhibitor

I am looking forhydroxychloroquine

I am looking forlasmiditan

I am looking for131i-mibg

I am looking forarginine hydrochloride

I am looking forhepatitis b surface antigen

I am looking foragalsidase beta

added new label for I am looking for

Advanced Filters

Found 413 clinical trials

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Family Medicine
Recruiting

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

paclitaxel

adjuvant

carboplatin

olaparib

carcinoma

Research Site

(5.1 away) Contact site

0 views
19 Feb, 2024
+94 other locations

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia

dementia

pick's disease

progranulin

Irving Institute for Clinical and Translational Research

(0.2 away) Contact site

0 views
19 Feb, 2024
+46 other locations

Multi-country trial
Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
all
Family Medicine
Recruiting

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

migraine

ly573144

lasmiditan

preventive medication

headache

Columbia University

(0.2 away) Contact site

0 views
19 Feb, 2024
+162 other locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Family Medicine
Recruiting

Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

adenocarcinoma

metastatic hormone refractory prostate cancer

orchiectomy

endocrine therapy

castration-resistant prostate cancer

Memorial Sloan-Kettering Cancer Center

(4.9 away) Contact site

0 views
19 Feb, 2024
+5 other locations

Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Endocrinology
Recruiting

A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

This research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.

systemic therapy

solid tumour

measurable disease

hysterectomy

serum pregnancy test

John Theurer Cancer Center at Hackensack University Medical Center

(6.4 away) Contact site

0 views
19 Feb, 2024
1 location

For pediatric ages
For adults
For Males
Family Medicine
Recruiting

ctgov trial 2

dddd

Test Site

(6.7 away) Contact site

0 views
19 Feb, 2024
1 location

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

monoclonal antibodies

lenalidomide

daratumumab

pomalidomide

refractory multiple myeloma

Investigational Site Number 8400001

(3.4 away) Contact site